Mentions
Extended reach
Total likes
Video views
AI synopsis
This collection exemplifies high interest and engagement through references to the development and clinical use of lipid nanoparticles, with phrases like 'engineered to overcome biological barriers' and 'potential for gene therapy,' illustrating enthusiasm and recognition of their transformative role in biotech. The tone and word choices emphasize advancements and future implications, reinforcing the perceived high impact of this research area.
All discussions emphasize the importance and success of lipid nanoparticles in overcoming biological barriers for nucleic acid delivery, indicating strong consensus on the article's positive outlook.
Participants show high interest, as reflected in detailed mentions of applications like vaccines and gene therapies, and recognition of technological progress over 20 years.
Many discussions delve into specifics, citing examples of advancements, clinical applications, and future potential, demonstrating deep engagement.
The collective tone suggests that these developments are viewed as game-changing, with mentions of applications in therapies and vaccines highlighting significant scientific and medical impact.
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0Aw7H https://t.co/VVqi2GK6ds
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0B3Xf https://t.co/x8owVjHco6
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0B3Xf https://t.co/cEfl5nMZU9
Biotechnology: Overcoming biological barriers to nucleic acid delivery using lipid nanoparticles | PLOS Biology https://t.co/Tkh0qBNXa5
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
Biotechnology aims to improve delivery of therapeutic nucleic acids by overcoming biological barriers using lipid nanoparticles. Ionizable lipid nanoparticles have been developed over 20 years, enabling effective…
RT @Pluchinolab: Biotechnology: Overcoming biological barriers to nucleic acid delivery using lipid nanoparticles | PLOS Biology https://t.…
Biotechnology: Overcoming biological barriers to nucleic acid delivery using lipid nanoparticles | PLOS Biology https://t.co/Tkh0qBNXa5
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0B3Xf https://t.co/cEfl5nMZU9
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0B3Xf https://t.co/x8owVjHco6
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
RT @PLOSBiology: Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic aci…
Over the past 20 years, lipid-based #nanoparticles have been engineered to overcome the biological barriers to nucleic acid delivery. In this Perspective, @mjmitchell_lab looks at their development for use in vaccines and therapies #PLOSBiology #biotech https://t.co/7gNOd0Aw7H https://t.co/VVqi2GK6ds
Biotechnology: Overcoming biological barriers to nucleic acid delivery using lipid nanoparticles https://t.co/Qko7Jl3VVV